Telesis Bio Launches Cell-free Amplification Kit for Transfection-scale DNA Generation
Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, has announced the commercial release of its BioXp® De novo Cloning and Amplification kit. This kit offers an efficient and automated solution for researchers to build and amplify DNA constructs to transfection-scale quantities in their labs. By bypassing the need for tedious bacterial scale-up and eliminating unpredictable service provider delivery times, this cell-free DNA amplification kit streamlines the workflow and reduces turnaround time.
Accelerating Workflow Timelines
The new kit empowers researchers to progress from sequence to functional screening in a matter of days instead of weeks. It enables iterative discovery applications such as antibody hit-to-lead screening and protein engineering, providing a robust and reliable solution to streamline workflow timelines.
Enhancing Molecular Biology Workflows
Telesis Bio's De Novo Cloning and Amplification kit complements their existing family of DNA amplification kits by allowing customers to generate amplified DNA directly from a designed sequence. This capability enables researchers to overcome molecular biology workflow bottlenecks in candidate screening, offering stability, control, and efficiency to accelerate the path to transformational therapies.
Empowering Scientists with Synthetic Biology Solutions
Telesis Bio is dedicated to empowering scientists to address humanity's greatest challenges through synthetic biology-enabled solutions. Their award-winning BioXp® systems automate and optimize the synthesis, cloning, and amplification workflow, enabling rapid and error-free synthesis of DNA and RNA at scale. This technology is utilized in various fields, including precision medicine, biologics drug discovery, vaccine development, genome editing, and cell and gene therapy.
In conclusion, Telesis Bio's Cell-free Amplification Kit for Transfection-scale DNA Generation offers researchers a powerful tool to accelerate their molecular biology workflows. By providing a streamlined and efficient solution, this kit contributes to the advancement of scientific discoveries and the development of transformative therapies.
Implications of Telesis Bio's Cell-free Amplification Kit for New Businesses
The launch of Telesis Bio's Cell-free Amplification Kit for Transfection-scale DNA Generation could have significant implications for new businesses in the biotechnology sector. The kit's ability to streamline and automate the process of building and amplifying DNA constructs could dramatically reduce the time and resources required for these tasks, potentially leading to increased productivity and reduced costs for businesses.
Boosting Efficiency and Reducing Turnaround Time
The kit's ability to bypass the need for bacterial scale-up and eliminate unpredictable service provider delivery times could be a game-changer for businesses. By reducing the turnaround time from sequence to functional screening, businesses could accelerate their research and development processes, potentially leading to faster product development and market entry.
Overcoming Workflow Bottlenecks
The kit's ability to enable the generation of amplified DNA directly from a designed sequence could help businesses overcome bottlenecks in molecular biology workflows. This could lead to more efficient candidate screening processes, potentially leading to faster discovery and development of transformative therapies.
Empowering Businesses with Synthetic Biology Solutions
Telesis Bio's commitment to empowering scientists with synthetic biology-enabled solutions could also have significant implications for businesses. By providing tools that automate and optimize synthesis, cloning, and amplification workflows, Telesis Bio could help businesses rapidly and accurately synthesize DNA and RNA at scale, potentially leading to breakthroughs in fields such as precision medicine, biologics drug discovery, vaccine development, genome editing, and cell and gene therapy.
In conclusion, Telesis Bio's Cell-free Amplification Kit for Transfection-scale DNA Generation could be a powerful tool for new businesses in the biotechnology sector, potentially leading to increased productivity, reduced costs, and faster product development.
.svg)
